Impelus Limited Announced the Launch of PLG Operations in The UK. Stock Zooms up by 10%

Impelus Limited (ASX: IMS), a digital customer acquisition company from the telecommunication services sector announced that with the launch of it’s Premium Lead Generation (PLG) in the insurance sector, it would significantly be expanding its Digital Performance Marketing (DPM) operations in the UK.

The major driving factor for launching Digital Performance Marketing (DPM) operations in the UK is that the UK’s population is thrice the population of Australia. Also, the company had received keen interest from the client based in the UK for using the latest IMS Premium Lead Generation technology to target their customer acquisition spend so that they could improve their financial returns.

The company is confident that through its extensive client base in the UK along with the Digital Lead Generation operations it can drive the introduction and use of our Premium Lead Generation technology. At the same time, the company is confident that all the parties would greatly be benefitted.

Sponsored ad by Kalkine

In Australia, the PLG operations were launched in March 2018, and it is running at an annual revenue run rate of around $3 million a year later. At present, the lead generation campaign is being run in the Health, Home and Education sectors. Still more sectors are under development.

The company will continue to enhance its technology platform further so that they are able to deliver the best to best solutions to Digital Lead Generation and Customer Acquisition solutions for businesses across industries. Thus, it is making solid and steady progress.

In the 1H FY2019, the company reported its operating revenue of $6.1 million and a normalized EBITDA of $0.29 million as a result of the impact of unforeseen factors on trading which reduced the residual carrier billing revenue. The UK business performed well during the period, giving a profitable performance.

Through the Premium Lead Generation (PLG), the revenue of the company by October 2018, has grown up from zero and it has reached $1.5 million annualized total revenue run rate basis. Impelus Limited also confirmed that in the second half of the financial year 2019, it would be focusing on the key growth areas in the Digital Performance Marketing (DPM) business for both Australia along with the UK.

During the period, the balance sheet of the company got strengthened. By the end of February 2019, the bank debt declined to $5.07 million which was $7.97 million at 31 December 2017. By the end of the half-year period on 31 December 2018, the net cash and cash equivalent were $1.12 million.

In the remaining part of FY19, the company expects an increased AU Premium Lead Generation business activity, followed by a stronger UK operation with expanded revenue stream followed by the cost reduction. The company expects these to be the driving factors for a stronger 2H FY2019 performance.

On 5 April 2019, Impelus Limited shared an update related to the favourable litigation.

At present, the shares of Impelus Limited is trading at A$0.011 (AEST: 2:58 pm, 11 April 2019), up by 10% as compared to its previous closing price. Impelus Limited has a market capitalization of A$6.92 million and approximately 692.22 million outstanding shares.


This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Facebook Comments
Join Our Forum

We help you to connect with investors and people connected with the stock market.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report


Please enter your comment!
Please enter your name here